New newborn screening for metabolic disorders
On Feb. 3, the U.S. Food and Drug Administration (FDA) permitted marketing of the Seeker System for the screening of four, rare Lysosomal Storage Disorders in newborns. Read…
Reader Survey
Please share your feedback! We’re interested to learn more about your experience with American Nurse Journal.
